1532
P. Feldhaus et al.
CLUSTER
Cardenas, A. J. P.; Warren, T. H.; Fröhlich, R.; Daniliuc, C.
Analytical Data of Compound 8
G.; Erker, G. J. Am. Chem. Soc. 2013, 135, 8882.
Anal. Calcd for C35H33BF15P: C, 53.87; H, 4.26. Found: C,
53.04; H, 4.22. Mp 141 °C (DSC). 1H NMR (600 MHz, 299
K, CD2Cl2): δ = 5.05 (d, 1JPH = 428.6 Hz, 1 H, PH), 4.97 (dq,
(8) (a) Otten, E.; Neu, R. C.; Stephan, D. W. J. Am. Chem. Soc.
2009, 131, 9918. (b) Cardenas, A. J. P.; Culotta, B. J.;
Warren, T. H.; Grimme, S.; Stute, A.; Fröhlich, R.; Kehr, G.;
Erker, G. Angew. Chem. Int. Ed. 2011, 50, 7567. (c) Sajid,
M.; Stute, A.; Cardenas, A. J. P.; Culotta, B. J.; Hepperle, J.
A. M.; Warren, T. H.; Schirmer, B.; Grimme, S.; Studer, A.;
Daniliuc, C. G.; Fröhlich, R.; Petersen, J. L.; Kehr, G.; Erker,
G. J. Am. Chem. Soc. 2012, 134, 10156. (d) Menard, G.;
Hatnean, J. A.; Cowley, H. J.; Lough, A. J.; Rawson, J. M.;
Stephan, D. W. J. Am. Chem. Soc. 2013, 135, 6446.
(e) Pereira, J. C. M.; Sajid, M.; Kehr, G.; Wright, A. M.;
Schirmer, B.; Qu, Z.-W.; Grimme, S.; Erker, G.; Ford, P. C.
J. Am. Chem. Soc. 2014, 136, 513.
(9) (a) Dobrovetsky, R.; Stephan, D. W. J. Am. Chem. Soc.
2013, 135, 4974. (b) Sajid, M.; Elmer, L.-M.; Rosorius, C.;
Daniliuc, C. G.; Grimme, S.; Kehr, G.; Erker, G. Angew.
Chem. Int. Ed. 2013, 52, 2243. (c) Sajid, M.; Lawzer, A.;
Dong, W.; Rosorius, C.; Sander, W.; Schirmer, B.; Grimme,
S.; Daniliuc, C. G.; Kehr, G.; Erker, G. J. Am. Chem. Soc.
2013, 135, 18567. (d) Sajid, M.; Kehr, G.; Daniliuc, C. G.;
Erker, G. Angew. Chem. Int. Ed. 2014, 53, 1118.
Z
2JPH = 2.7 Hz, 4JHH = 1.0 Hz, 1 H, =CH2 ), 4.92 (dq,
E
2JPH = 2.7 Hz, 4JHH = 1.5 Hz, 1 H, =CH2 ), 1.82 (dd,
4JHH = 1.5 Hz, 4JHH = 1.0 Hz, 3 H, CH3), 1.63 (d, 3JPH = 15.9
Hz, 27 H, t-Bu). 13C{1H} NMR (151 MHz, 299 K, CD2Cl2):
δ = 148.6 (dm, 1JFC = ca. 240 Hz, C6F5), 138.5 (dm, 1JFC = ca.
250 Hz, C6F5), 136.9 (dm, 1JFC = ca. 240 Hz, C6F5), 130.8
(=C), 124.8 (br, ipso-C6F5), 116.8 (=CH2), 95.4 (br, ≡C),
38.1 (d, 1JPC = 26.8 Hz, t-Bu), 30.4 (t-Bu), 24.4 (CH3);
resonance for ≡CB was not observed. 31P NMR (243 MHz,
299 K, CD2Cl2): δ = 60.4 (dm, 1JPH = 428.6 Hz). 11B{1H}
NMR (192 MHz, 299 K, CD2Cl2): δ = –21.0 (ν1/2 = ca. 25
Hz). 19F NMR (564 MHz, 299 K, CD2Cl2): δ = –132.6 (m,
2 F, o-C6F5), –164.0 (t, 3JFF = 20.3 Hz, 1 F, p-C6F5), –167.4
(m, 2 F, m-C6F5), [Δδ19Fm,p = 3.4].
Analytical Data of Compound 9a
HRMS: m/z calcd for C35H33BF15PNa+: 803.2072; found:
803.2031. Decomposition: 247 °C (DSC). 1H NMR (600
MHz, 298 K, CD2Cl2): δ = 5.94 (br m, 1 H, =CH), 3.13 (ddd,
2JPH = 16.2 Hz, 2JHH = 14.8 Hz, 5JHH = 3.1 Hz, 1 H, CH2),
2.26 (ddd, 2JPH = 15.5 Hz, 2JHH = 14.8 Hz, 5JHH = 1.3 Hz,
1 H, CH2), 1.66 (br d, 4JPH = 3.1 Hz, 3 H, CH3), 1.57 (d,
3JPH = 13.9 Hz, 27 H, t-Bu). 13C{1H} NMR (151 MHz, 298
K, CD2Cl2): δ = 207.1 (d, 3JPC = 6.7 Hz, =C=), 148.4 (dm,
1JFC = ca. 238 Hz, C6F5), 138.4 (dm, 1JFC = ca. 231 Hz, C6F5),
136.8 (dm, 1JFC = ca. 233 Hz, C6F5), 125.1 (br, i-C6F5), 98.5
[br q (1:1:1:1), 1JBC = ca. 50 Hz, =CH], 80.0 (br m, =C), 39.7
(d, 1JPC = 27.4 Hz, t-Bu), 30.4 (t-Bu), 23.5 (d, 1JPC = 31.4
Hz, CH2), 23.1 (d, 3JPC = 3.2 Hz, CH3). 31P{1H} NMR (243
MHz, 298 K, CD2Cl2): δ = 49.2 (ν1/2 = ca. 10 Hz). 11B{1H}
NMR (192 MHz, 298 K, CD2Cl2): δ = –15.6 (ν1/2 = ca. 15
Hz). 19F NMR (564 MHz, 298 K, CD2Cl2): δ = –132.2 (m, 2
F o-C6F5), –163.6 (t, 3JFF = 20.4 Hz, 1 F, p-C6F5), –167.4 (m,
2 F, m-C6F5), [Δδ19Fm,p = 3.8].
(10) Ekkert, O.; Miera, G. G.; Wiegand, T.; Eckert, H.; Schirmer,
B.; Petersen, J. L.; Daniliuc, C. G.; Fröhlich, R.; Grimme, S.;
Kehr, G.; Erker, G. Chem. Sci. 2013, 4, 2657.
(11) (a) Ullrich, M.; Seto, K. S.-H.; Lough, A. J.; Stephan, D. W.
Chem. Commun. 2009, 2335. (b) Dureen, M. A.; Stephan, D.
W. J. Am. Chem. Soc. 2009, 131, 8396. (c) Mömming, C.
M.; Frömel, S.; Kehr, G.; Fröhlich, R.; Grimme, S.; Erker, G.
J. Am. Chem. Soc. 2009, 131, 12280. (d) Chen, C.; Eweiner,
F.; Wibbeling, B.; Fröhlich, R.; Senda, S.; Ohki, Y.;
Tatsumi, K.; Grimme, S.; Kehr, G.; Erker, G. Chem. Asian J.
2010, 5, 2199. (e) Dureen, M. A.; Brown, C. C.; Stephan, D.
W. Organometallics 2010, 29, 6594. (f) Voss, T.; Chen, C.;
Kehr, G.; Nauha, E.; Erker, G.; Stephan, D. W. Chem. Eur.
J. 2010, 16, 3005. (g) Voss, T.; Sortais, J.-B.; Fröhlich, R.;
Kehr, G.; Erker, G. Organometallics 2011, 30, 584.
(h) Zhao, X.; Stephan, D. W. Chem. Sci. 2012, 3, 2123.
(12) Xu, B.; Kehr, G.; Fröhlich, R.; Wibbeling, B.; Schirmer, B.;
Grimme, S.; Erker, G. Angew. Chem. Int. Ed. 2011, 50,
7183.
(17) Compounds 10 and 9b
A solution of tri-ortho-tolylphosphane (152 mg, 0.50 mmol)
in CD2Cl2 (4 mL) was added to a solution of tris(pentafluoro-
phenyl)borane (256 mg, 0.50 mmol) in CD2Cl2 (4 mL) at r.t.
Then the reaction mixture was added to 2-methyl-1,3-
butenyne (33 mg, 47.5 μL, 0.50 mmol), and the resulting
mixture was stirred for 10 min. After one day, an aliquot of
the reaction mixture was investigated by NMR experiments
at low temperature. A mixture of compound 10 (1,2-
addition), compound 9b (1,4-addition) and tri-ortho-
tolylphosphane. [10/9b/phosphane = ca. 28:37:35 (1H NMR
at 248 K)] was characterized. Then the volume of the
reaction mixture was reduced to one half followed by
separation of the compounds by column chromatography
(silica gel; eluent CH2Cl2–n-pentane = 2:3). The first
fraction contained compound 10 admixed with tri-ortho-
tolylphosphane, which subsequently was purified by
crystallization from a solution of compound 10 in CH2Cl2
layered by n-pentane to give compound 10 (89 mg, 20%).
The second fraction contained compound 9b (148.9 mg,
33%). Crystals suitable for the X-ray crystal structure
analysis for both compounds 10 and 9b, respectively, were
obtained from a solution of the respective compound in
CH2Cl2 layered with n-pentane at –40 °C.
(13) Mömming, C. M.; Kehr, G.; Wibbeling, B.; Fröhlich, R.;
Schirmer, B.; Grimme, S.; Erker, G. Angew. Chem. Int. Ed.
2010, 49, 2414.
(14) Feldhaus, P.; Schirmer, B.; Wibbeling, B.; Daniliuc, C. G.;
Fröhlich, R.; Grimme, S.; Kehr, G.; Erker, G. Dalton Trans.
2012, 41, 9135.
(15) Kalinowski, H.-O.; Berger, S.; Braun, S. In 13C NMR-
Spektroskopie; Thieme: Stuttgart, 1984.
(16) Compounds 8 and 9a
Tri-tert-butylphosphane (102 mg, 0.50 mmol) in CH2Cl2
(3 mL) was added to a solution of tris(pentafluorophenyl)-
borane (256 mg, 0.50 mmol) in CH2Cl2 (10 mL). After
addition of 2-methyl-1,3-butenyne (33 mg, 47.5 μL, 0.50
mmol) the reaction mixture was stirred for 24 h at r.t.
Subsequently, all volatiles were removed under reduced
pressure and the obtained residue was dried in vacuo to give
a ca. 1:1 mixture of compounds 8 and 9a (302 mg). The both
products were separated by column chromatography (silica
gel; eluent: n-pentane–CH2Cl2, 3:5). Drying of the
respective fraction in vacuo gave compound 8 (131.9 mg,
33%) and compound 9a (81.6 mg, 21%). Crystals suitable
for the X-ray crystal structure analysis for both compound 8
and compound 9a were obtained from a solution of the
respective compound in CH2Cl2 layered by n-pentane at
–40 °C.
Analytical Data of Compound 10
Anal. Calcd for C44H27BF15P·CH2Cl2: C, 55.87; H, 3.02.
Found: C, 55.50; H, 2.55. Mp 98 °C (DSC). 1H NMR (500
MHz, 233 K, CD2Cl2): δ = 8.27 (br d, 3JPH = 37.0 Hz, 1 H,
=CH), 7.86 (o), 7.63 (p), 7.51 (m), 7.33 (m′) (4 × m, 4 × 1 H,
o-tola), 7.65 (p), 7.60 (o), 7.43 (m), 7.36 (m′) (4 × m, 4 × 1 H,
Synlett 2014, 25, 1529–1533
© Georg Thieme Verlag Stuttgart · New York